IgA Nephropathy Treatment with Traditional Chinese Medicine: A Case Report

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2022 Jun 1

PMID 35647137

Authors

Ying-Yu Zhang

Yan-Lin Chen

Lan Yi

Kun Gao

Affiliations

Soon will be listed here.

Abstract

Background: IgA nephropathy (IgAN) is a common primary glomerular disease that leads to end-stage renal disease with poor therapy efficacy. Traditional Chinese medicine (TCM) is effective in the treatment of IgAN and has the potential to become an alternative treatment for IgAN. Professor Yan-Qin Zou is a nephropathy expert, a National Chinese Medicine Master, and an heir to the Menghe School of Medicine.

Case Summary: A 28-year-old man had positive urinary protein and elevated serum creatinine (Scr) results and was diagnosed with IgAN 2-3 years prior to the outpatient department visit at our hospital in 2017. Professor Zou used the following methods to treat the patient: Invigorating the spleen and tonifying the kidney, removing dampness and clearing turbidity, quickening the blood and transforming stasis, and freeing vessels and regulating collaterals. She adjusted the prescription in accordance with the patient's symptoms. After 6 mo of treatment, the symptoms had resolved and serological indexes were also decreased [Scr from 288.5 to 188.6 µmol/L, blood urea nitrogen (BUN) from 10.9 to 9.5 mmol/L, serum uric acid (UA) from 612 to 503 µmol/L]. During follow-up, BUN, Scr, and UA levels remained stable.

Conclusion: Professor Zou's therapeutic strategy to treat IgAN using TCM was efficacious and a good reference for application.

References

Gao Q, Yang M, Zuo Z . Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L. Acta Pharmacol Sin. 2018; 39(5):787-801. PMC: 5943914. DOI: 10.1038/aps.2018.32. View

Tapsell L, Hemphill I, Cobiac L, Patch C, Sullivan D, Fenech M . Health benefits of herbs and spices: the past, the present, the future. Med J Aust. 2006; 185(S4):S1-S24. DOI: 10.5694/j.1326-5377.2006.tb00548.x. View

Heerspink H, Stefansson B, Correa-Rotter R, Chertow G, Greene T, Hou F . Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020; 383(15):1436-1446. DOI: 10.1056/NEJMoa2024816. View

Nagy J, Sagi B, Mate J, Vas T, Kovacs T . [Considerations on the treatment of IgA nephropathy on the basis of the results of the latest studies (STOP-IgAN, TESTING, NEFIGAN)]. Orv Hetil. 2017; 158(49):1946-1952. DOI: 10.1556/650.2017.30924. View

Li W, He W, Xia P, Sun W, Shi M, Zhou Y . Total Extracts of L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation. Front Pharmacol. 2019; 10:567. PMC: 6548014. DOI: 10.3389/fphar.2019.00567. View

Zhong Y, Deng Y, Chen Y, Chuang P, He J . Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int. 2013; 84(6):1108-18. PMC: 3812398. DOI: 10.1038/ki.2013.276. View

Ammirati A . Chronic Kidney Disease. Rev Assoc Med Bras (1992). 2020; 66Suppl 1(Suppl 1):s03-s09. DOI: 10.1590/1806-9282.66.S1.3. View

Zhong Y, Menon M, Deng Y, Chen Y, He J . Recent Advances in Traditional Chinese Medicine for Kidney Disease. Am J Kidney Dis. 2015; 66(3):513-22. DOI: 10.1053/j.ajkd.2015.04.013. View

Li N, Tang H, Wu L, Ge H, Wang Y, Yu H . Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases. Phytother Res. 2020; 35(1):198-206. PMC: 7891592. DOI: 10.1002/ptr.6818. View

10.

Li X, Wang H . Chinese herbal medicine in the treatment of chronic kidney disease. Adv Chronic Kidney Dis. 2005; 12(3):276-81. DOI: 10.1016/j.ackd.2005.03.007. View

11.

Zhang L, Li P, Xing C, Zhao J, He Y, Wang J . Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial. Am J Kidney Dis. 2014; 64(1):57-65. DOI: 10.1053/j.ajkd.2014.01.431. View

12.

Lu W, Lu D . Impact of chinese herbal medicine on american society and health care system: perspective and concern. Evid Based Complement Alternat Med. 2014; 2014:251891. PMC: 3955605. DOI: 10.1155/2014/251891. View

13.

Rodrigues J, Haas M, Reich H . IgA Nephropathy. Clin J Am Soc Nephrol. 2017; 12(4):677-686. PMC: 5383386. DOI: 10.2215/CJN.07420716. View

14.

Wang X, Lang R, Liang Y, Zeng Q, Chen N, Yu R . Traditional Chinese Medicine in Treating IgA Nephropathy: From Basic Science to Clinical Research. J Transl Int Med. 2021; 9(3):161-167. PMC: 8629415. DOI: 10.2478/jtim-2021-0021. View

15.

Li L, Liu Z . Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004; 66(3):920-3. DOI: 10.1111/j.1523-1755.2004.00837.x. View

16.

Hu M, Yu Z, Wang J, Fan W, Liu Y, Li J . Traditional Uses, Origins, Chemistry and Pharmacology of Bombyx batryticatus: A Review. Molecules. 2017; 22(10). PMC: 6151799. DOI: 10.3390/molecules22101779. View

17.

Wojcikowski K, Johnson D, Gobe G . Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med. 2006; 147(4):160-6. DOI: 10.1016/j.lab.2005.11.011. View

18.

Haas M . Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997; 29(6):829-42. DOI: 10.1016/s0272-6386(97)90456-x. View

19.

Cattran D, Coppo R, Cook H, Feehally J, Roberts I, Troyanov S . The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009; 76(5):534-45. DOI: 10.1038/ki.2009.243. View

20.

Peng A, Gu Y, Lin S . Herbal treatment for renal diseases. Ann Acad Med Singap. 2005; 34(1):44-51. View